Predisposition to multi-drug hypersensitivity after administration of mogamulizumab

Eur J Dermatol. 2018 Aug 1;28(4):526-528. doi: 10.1684/ejd.2018.3309.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Diuretics / adverse effects
  • Drug Eruptions / etiology*
  • Esomeprazole / adverse effects
  • Factor Xa Inhibitors / adverse effects
  • Fatal Outcome
  • Female
  • Furosemide / adverse effects
  • Humans
  • Immunologic Factors / adverse effects
  • Lenalidomide / adverse effects
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy
  • Middle Aged
  • Proton Pump Inhibitors / adverse effects
  • Pyridines / adverse effects
  • Thiazoles / adverse effects
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Diuretics
  • Factor Xa Inhibitors
  • Immunologic Factors
  • Proton Pump Inhibitors
  • Pyridines
  • Thiazoles
  • Furosemide
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Lenalidomide
  • Esomeprazole
  • edoxaban
  • mogamulizumab